National and Kapodistrian University of Athens
Λοιμώξεις στους ασθενείς της Μονάδας Εντατικής Θεραπείας (ΜΕΘ): συσχέτιση ανάπτυξης πολυανθεκτικών στελεχών με την κλινική έκβαση
Abstract
dc:descriptionTo analyze the risk factors involved in the development of carbapenem resistant Gram-negative bacteremia (GNB) and to evaluate the outcome of infected critically ill patients. All patients admitted to the 25-bed multidisciplinary ICU of Evangelismos Hospital in Athens, during an 18-month period, who developed a nosocomial GNB were studied prospectively. Of 855 consecutively admitted ICU patients, with > 48h ICU stay, 84 who developed carbapenem susceptible GNB were compared to 85 patients with carbapenem resistant GNB. The lungs were the main source of infection in both groups. The main resistant pathogens were Acinetobacter baumannii 32 (37.6%) and Pseudomonas aeruginosa 31 (36.5%). Patients infected with carbapenem resistant isolates developed ventilator -associated pneumonia more often than those with susceptible 60% vs. 34.5%, respectively, p< 0.001. Also they had a longer ICU stay (30 vs. 23 days, median value, p= 0.035), a longer ICU stay prior to bacteremia onset (14 vs. 11 days, median value, p= 0.026), prolonged previous use of carbapenems [10 (5-18) vs. 3 (0-11) days, median value, p< 0.001] and of colistin [1 (0-12) vs. 0 (0-0) days, median value, p< 0.001]. Mortality, although higher in patients with carbapenem resistant GNB, compared to those with carbapenem susceptible was not statistically significant (48% vs. 45%, p= 0.696). By multiple analysis, SOFA score on GNB onset ( OR, 1.44; 95% CI 1.26-1.66, p< 0.001) and the total number of intravascular devices (OR, 2.45; 95% CI 1.16-5.15, p= 0.019) independently affected the outcome. Among the 84 patients with carbapenem susceptible pathogens, SOFA score on bacteremia day (OR, 1.39; 95% CI 1.16-1.69, p< 0.001) and serum albumin level on bacteremia day (OR, 0.31; 95% CI 0.11-0.88, p= 0.029) were independent factors for mortality. Among the 85 patients with carbapenem resistant GNB, SOFA score on bacteremia day (OR, 1.46; 95% CI 1.17-1.83, p= 0.001), total number of intravascular devices (OR, 4.59; 95% CI 1.38-15.27, p= 0.013) and the presence of candidemia (OR, 7.32; 95% CI 1.12-47.99, p= 0.038) were independently associated with mortality. In critically ill patients, VAP and prolonged previous use of carbapenems and colistin predispose to carbapenem resistant GNB. Mortality rate was higher among patients with carbapenem resistant GNB, compared to those with carbapenem susceptible, but not statistically significant.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pratikaki, Maria
- Πρατικάκη, Μαρία
Subjects
dc:subject × 20- Gram αρνητική βακτηριαιμία
- Πνευμονία σχετιζόμενη με τον αναπνευστήρα (VAP)
- Βαρέως πάσχοντες ασθενείς
- Μονάδα εντατικής θεραπείας ( ΜΕΘ )
- Αντιμικροβιακοί παράγοντες
- Καρβαπενέμες
- Αντοχές
- Θνητότητα
- Gram negative bacteremia
- VAP
- Critical ill patients
- Intensive care units (ICU)
- Antimicrobials
- Carbapenems
- Resistance
- Mortality
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22493